These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15475426)

  • 1. More than a marker... Phosphorylated Akt in prostate carcinoma.
    Stern DF
    Clin Cancer Res; 2004 Oct; 10(19):6407-10. PubMed ID: 15475426
    [No Abstract]   [Full Text] [Related]  

  • 2. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
    Ayala G; Thompson T; Yang G; Frolov A; Li R; Scardino P; Ohori M; Wheeler T; Harper W
    Clin Cancer Res; 2004 Oct; 10(19):6572-8. PubMed ID: 15475446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
    Van de Sande T; Roskams T; Lerut E; Joniau S; Van Poppel H; Verhoeven G; Swinnen JV
    J Pathol; 2005 Jun; 206(2):214-9. PubMed ID: 15880754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.
    Edwards J; Bartlett JM
    BJU Int; 2005 Jun; 95(9):1320-6. PubMed ID: 15892825
    [No Abstract]   [Full Text] [Related]  

  • 6. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.
    Paweletz CP; Charboneau L; Bichsel VE; Simone NL; Chen T; Gillespie JW; Emmert-Buck MR; Roth MJ; Petricoin III EF; Liotta LA
    Oncogene; 2001 Apr; 20(16):1981-9. PubMed ID: 11360182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
    Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
    Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y; Sarkar FH
    Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells.
    Siddiqui IA; Adhami VM; Afaq F; Ahmad N; Mukhtar H
    J Cell Biochem; 2004 Feb; 91(2):232-42. PubMed ID: 14743383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosis.
    Clarke RB
    Breast Cancer Res; 2003; 5(3):162-3. PubMed ID: 12793899
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased phospho-AKT is associated with loss of the androgen receptor during the progression of N-methyl-N-nitrosourea-induced prostate carcinogenesis in rats.
    Liao Z; Wang S; Boileau TW; Erdman JW; Clinton SK
    Prostate; 2005 Jul; 64(2):186-99. PubMed ID: 15682402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
    Malik SN; Brattain M; Ghosh PM; Troyer DA; Prihoda T; Bedolla R; Kreisberg JI
    Clin Cancer Res; 2002 Apr; 8(4):1168-71. PubMed ID: 11948129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells.
    Uzgare AR; Isaacs JT
    Cancer Res; 2004 Sep; 64(17):6190-9. PubMed ID: 15342404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos.
    Gapter L; Wang Z; Glinski J; Ng KY
    Biochem Biophys Res Commun; 2005 Jul; 332(4):1153-61. PubMed ID: 15913545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.
    Zhuang L; Lin J; Lu ML; Solomon KR; Freeman MR
    Cancer Res; 2002 Apr; 62(8):2227-31. PubMed ID: 11956073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
    Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
    Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal prostate epithelial cells stimulate the migration of prostate cancer cells.
    Yu HM; Frank DE; Zhang J; You X; Carter WG; Knudsen BS
    Mol Carcinog; 2004 Oct; 41(2):85-97. PubMed ID: 15378647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry.
    Tazzari PL; Cappellini A; Grafone T; Mantovani I; Ricci F; Billi AM; Ottaviani E; Conte R; Martinelli G; Martelli AM
    Br J Haematol; 2004 Sep; 126(5):675-81. PubMed ID: 15327518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
    Min YH; Cheong JW; Kim JY; Eom JI; Lee ST; Hahn JS; Ko YW; Lee MH
    Cancer Res; 2004 Aug; 64(15):5225-31. PubMed ID: 15289327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.